Blood Advances

Published by: American Society of Hematology  

People

  1. Salles
    Salles
  2. Palomba
    Palomba
  3. Hamlin
    Hamlin
  4. Horwitz
    Horwitz
  5. Moskowitz
    Moskowitz
  6. Zelenetz
    Zelenetz
  7. Devlin
    Devlin
  8. Falchi
    Falchi
  9. Kumar
    Kumar
  10. Noy
    Noy

Groups

  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (17)
  3. Center for Hematologic Malignancies (10)
  4. Lymphoma (10)
  5. Epidemiology and Biostatistics (8)
  6. Survivorship Research (7)
  7. Biostatistics Service (6)
  8. Graduate Medical Education (6)
  9. Hematology-Oncology Fellows (6)
  10. GME, Medicine (5)
Search Within
  1. "Gilles Salles"
Formats
  1. Journal Article (13)
  2. Research Letter (4)
Groups
  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (17)
  3. Center for Hematologic Malignancies (10)
  4. Lymphoma (10)
  5. Epidemiology and Biostatistics (8)
  6. Survivorship Research (7)

More Groups

People
  1. Gilles Salles (17)
  2. Maria Palomba (7)
  3. Paul Hamlin (5)
  4. Alison Moskowitz (4)
  5. Andrew Zelenetz (4)
  6. Connie Batlevi (4)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (4)
  4. 2022 (5)
  5. 2021 (2)
Publishers
  1. American Society of Hematology (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants
    Journal Article

    Ghione, P.; Mandelker, D.; Arcila, M.; Seshan, V.; Terry, M. B.; Vijai, J.; Cordeiro, P.; Vanderbilt, C.; Pressley, J.; Chan, A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes
    Research Letter

    Trněný, M.; Fogliatto, L.; Gardner, F.; Flinn, I.; Larouche, J. F.; Haioun, C.; Canales, M.; Goto, H.; Hajek, R.; Salles, G.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Journal Article

    Cederquist, G. Y.; Schefflein, J.; Devlin, S. M.; Shah, G. L.; Shouval, R.; Hubbeling, H.; Tringale, K.; Tomas, A. A.; Fregonese, B.; Hajj, C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
    Research Letter

    Zinzani, P. L.; Salles, G.; Moskowitz, A. J.; Santoro, A.; Mehta, A.; Barr, P. M.; Mehta-Shah, N.; Collins, G. P.; Ansell, S. M.; Brody, J. D.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Journal Article

    Bantilan, K. S.; Smith, A. N.; Maurer, M. J.; Teruya-Feldstein, J.; Matasar, M. J.; Moskowitz, A. J.; Straus, D. J.; Noy, A.; Palomba, M. L.; Horwitz, S. M.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Phase 3 SELENE study: Ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
    Journal Article

    Nastoupil, L. J.; Hess, G.; Pavlovsky, M. A.; Danielewicz, I.; Freeman, J.; García-Sancho, A. M.; Glazunova, V.; Grigg, A.; Hou, J. Z.; Janssens, A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
    Journal Article

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Moskowitz, A. J.; Stuver, R. N.; Maccaro, C. R.; Galasso, N.; Chang, T.; Khan, N.; Aypar, U.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
    Research Letter

    Lin, R. J.; Kim, S. J.; Brown, S.; Elko, T. A.; Ruiz, J. D.; Hanley, D. M.; Palomba, M. L.; Perales, M. A.; Shah, G. L.; Dahi, P. B.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save

    • Blood Advances – authorized name for:

    Name ISSN / ISBN Publisher
    Blood Advances 2473-9529 American Society of Hematology
    Blood Advances 24739529 American Society of Hematology
    Blood Advances 24739529 Unknown
    Blood advances 24739537 American Society of Hematology
    Blood Advances 2473-9529 American Society of Hematology
    Blood Advances 24739529 American Society of Hematology
    Blood Advances 24739529 Elsevier Inc.
    Blood Advances 24739529 Elsevier B.V.
    Blood Advances 24739529 Elsevier Inc.
    Blood Advances 2473-9529 American Society of Hematology
    Blood Advances 2473-9529 American Society of Hematology
    Blood advances 2473-9529 American Society of Hematology
    Blood Advances 24739529 Begell House, Inc
    Blood Advances 2473-9529 Elsevier Inc.